Urease-IN-13

• UNSPSC Description:

  Urease-IN-13 (compound d8) is an inhibitor of urease with an IC50 value of 1.21 μM. Urease-IN-13 can be used in the study of infectious gastritis and gastric ulcer[1].

• Target Antigen:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/urease-in-13.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1OC(CC2=NNC(O2)=O)CN1C3=CC=CC=C3OCC4=CC=CC=C4

• Molecular Weight:

  367.36

• References & Citations:

  [1]Wang YN, et al. Synthesis and biological evaluation of triazolones/oxadiazolones as novel urease inhibitors. Bioorg Med Chem. 2024;102:117656.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported